Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
23
RHHBF Quote, Financials, Valuation and Earnings
Last price:
$284.70
Seasonality move
:
-0.85%
Day range:
$284.70 - $284.70
52-week range:
$243.42 - $368.43
Dividend yield:
3.84%
P/E ratio:
19.28x
P/S ratio:
3.38x
P/B ratio:
7.05x
Volume:
25
Avg. volume:
124
1-year change:
-4.78%
Market cap:
$226.8B
Revenue:
$67.3B
EPS (TTM):
$14.76
Analysts' Opinion
-
Consensus RatingRoche Holding AG has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Roche Holding AG has an estimated downside of -83.14% from its current price of $284.70.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $284.70.
Fair Value
-
According to the consensus of 0 analysts, Roche Holding AG has -83.14% downside to fair value with a price target of -- per share.
RHHBF vs. S&P 500
-
Over the past 5 trading days, Roche Holding AG has overperformed the S&P 500 by 1.65% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Roche Holding AG does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Roche Holding AG has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Roche Holding AG reported revenues of --.
Earnings Growth
-
Roche Holding AG has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Roche Holding AG reported earnings per share of --.
Enterprise value:
259.7B
EV / Invested capital:
--
Price / LTM sales:
3.38x
EV / EBIT:
16.25x
EV / Revenue:
3.84x
PEG ratio (5yr expected):
--
EV / Free cash flow:
20.50x
Price / Operating cash flow:
18.05x
Enterprise value / EBITDA:
13.16x
Gross Profit (TTM):
$49.5B
Return On Assets:
11.53%
Net Income Margin (TTM):
17.5%
Return On Equity:
32.32%
Return On Invested Capital:
16.82%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-23 | 2023-12-23 | 2023-12-23 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $29.1B | $33.9B | $31.8B | $34.4B | $37.4B | |
| Total Assets | $84.5B | $95.4B | $90.9B | $93.8B | $106.6B | |
| Current Liabilities | $23.6B | $27.4B | $28.7B | $29.1B | $29.6B | |
| Total Liabilities | $47.9B | $50.4B | $60.6B | $60.1B | $70B | |
| Total Equity | $36.6B | $45B | $30.3B | $33.7B | $36.6B | |
| Total Debt | $15.8B | $16.3B | $29.1B | $28.2B | $38.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-23 | 2023-12-23 | 2023-12-23 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
RHHBF
Sector
Market Cap
$226.8B
$44.6M
Price % of 52-Week High
77.27%
45.71%
Dividend Yield
3.84%
0%
Shareholder Yield
2.45%
-0.68%
1-Year Price Total Return
-4.78%
-29.09%
Beta (5-Year)
0.357
0.772
Dividend yield:
3.84%
Annualized payout:
$10.20
Payout ratio:
71.44%
Growth streak:
2 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$300.35
200-day SMA
Sell
Level
$308.76
Bollinger Bands (100)
Sell
Level
310.88 - 352.6
Chaikin Money Flow
Sell
Level
-77.9K
20-day SMA
Sell
Level
$304.90
Relative Strength Index (RSI14)
Sell
Level
39.15
ADX Line
Sell
Level
7.14
Williams %R
Buy
Level
-100
50-day SMA
Sell
Level
$323.45
MACD (12, 26)
Sell
Level
-6.27
25-day Aroon Oscillator
Sell
Level
-36
On Balance Volume
Sell
Level
-1M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.0934)
Buy
CA Score
(Annual)
Level (-0.28)
Buy
Beneish M-Score
(Annual)
Level (-2.5965)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-1.329)
Buy
Piotroski F Score
(Annual)
Level (7)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Stock Forecast FAQ
In the current month, RHHBF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The RHHBF average analyst price target in the past 3 months is --.
-
Where Will Roche Holding AG Stock Be In 1 Year?
According to analysts, the consensus estimate is that Roche Holding AG share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Roche Holding AG?
Analysts are divided on their view about Roche Holding AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Roche Holding AG is a Sell and believe this share price will rise from its current level to --.
-
What Is Roche Holding AG's Price Target?
The price target for Roche Holding AG over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is RHHBF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Roche Holding AG is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of RHHBF?
You can purchase shares of Roche Holding AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Roche Holding AG shares.
-
What Is The Roche Holding AG Share Price Today?
Roche Holding AG was last trading at $284.70 per share. This represents the most recent stock quote for Roche Holding AG. Yesterday, Roche Holding AG closed at $284.70 per share.
-
How To Buy Roche Holding AG Stock Online?
In order to purchase Roche Holding AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
